← All news

TürkiyeResearch and clinical trials

Moving to adult care in DMD in Türkiye: most patients found the preparation inadequate

Peer-reviewed publication

A study published in a journal and reviewed by independent scientists. Even so, a single study is not conclusive; it needs to be replicated.

In Türkiye, the move of young people with DMD (Duchenne muscular dystrophy) from child neurology to adult neurology was studied. The survey included 62 doctors from 28 provinces and 48 patients and caregivers. Only 18% of the doctors said their institution had a regular transition program. Of the patients who had made the move, 62% found the preparation inadequate. Most patients first heard about the move at age 17 or later.

What does it mean for patients and families?

It may help families to discuss the transition plan with the doctor early. The study was carried out to form the basis of a national transition guide.

Source

PubMed (Orphanet Journal of Rare Diseases): Transition from pediatric to adult neurology care in Duchenne muscular dystrophy: a national survey of patient and physician experiences

Scientific paper: Transition from pediatric to adult neurology care in Duchenne muscular dystrophy: a national survey of patient and physician experiences. Orphanet Journal of Rare Diseases, 2026. DOI: 10.1186/s13023-026-04454-8 · PubMed 42332730

The source page was opened and read on October 7, 2026. Summary prepared by the Doktorclub editorial team and translated from Turkish; it has not yet been reviewed by a physician (a scientific board is being set up).

This page is translated from the Turkish original.

This page reports a development; it is not a treatment recommendation. Your doctor decides whether a treatment is right for you.

The information on these pages is for general information only and does not replace medical advice. Talk to your doctor about diagnosis and treatment decisions. In an emergency in Türkiye, call 112.

Every update is based on an open source and labeled with its level of evidence. No advertising and no drug brand names. Our scientific principles

This page was translated from Turkish by the Doktorclub editorial team.